TY - JOUR
T1 - The role of the dopamine D1 receptor in social cognition
T2 - Studies using a novel genetic rat model
AU - Homberg, Judith R.
AU - Olivier, Jocelien D.A.
AU - VandenBroeke, Marie
AU - Youn, Jiun
AU - Ellenbroek, Arabella K.
AU - Karel, Peter
AU - Shan, Ling
AU - Van Boxtel, Ruben
AU - Ooms, Sharon
AU - Balemans, Monique
AU - Langedijk, Jacqueline
AU - Muller, Mareike
AU - Vriend, Gert
AU - Cools, Alexander R.
AU - Cuppen, Edwin
AU - Ellenbroek, Bart A.
N1 - Publisher Copyright:
© 2016. Published by The Company of Biologists Ltd.
PY - 2016/10/1
Y1 - 2016/10/1
N2 - Social cognitionisan endophenotype that is impaired in schizophrenia and several other (comorbid) psychiatric disorders. One of the modulators of social cognition is dopamine, but its role is not clear. The effects of dopamine are mediated through dopamine receptors, including the dopamine D1 receptor (Drd1). Because current Drd1 receptor agonists are not Drd1 selective, pharmacological tools are not sufficient to delineate the role of the Drd1. Here, we describe a novel rat model with a genetic mutation in Drd1 in which we measured basic behavioural phenotypes and social cognition. The I116S mutation was predicted to render the receptor less stable. In line with this computational prediction, this Drd1 mutation led to a decreased transmembrane insertion of Drd1, whereas Drd1 expression, as measured by Drd1 mRNA levels, remained unaffected. Owing to decreased transmembrane Drd1 insertion, the mutant rats displayed normal basic motoric and neurological parameters, as well as locomotor activity and anxiety-like behaviour. However, measures of social cognition like social interaction, scent marking, pup ultrasonic vocalizations and sociability, were strongly reduced in the mutant rats. This profile of the Drd1 mutant rat offers the field of neuroscience a novel genetic rat model to study a series of psychiatric disorders including schizophrenia, autism, depression, bipolar disorder and drug addiction.
AB - Social cognitionisan endophenotype that is impaired in schizophrenia and several other (comorbid) psychiatric disorders. One of the modulators of social cognition is dopamine, but its role is not clear. The effects of dopamine are mediated through dopamine receptors, including the dopamine D1 receptor (Drd1). Because current Drd1 receptor agonists are not Drd1 selective, pharmacological tools are not sufficient to delineate the role of the Drd1. Here, we describe a novel rat model with a genetic mutation in Drd1 in which we measured basic behavioural phenotypes and social cognition. The I116S mutation was predicted to render the receptor less stable. In line with this computational prediction, this Drd1 mutation led to a decreased transmembrane insertion of Drd1, whereas Drd1 expression, as measured by Drd1 mRNA levels, remained unaffected. Owing to decreased transmembrane Drd1 insertion, the mutant rats displayed normal basic motoric and neurological parameters, as well as locomotor activity and anxiety-like behaviour. However, measures of social cognition like social interaction, scent marking, pup ultrasonic vocalizations and sociability, were strongly reduced in the mutant rats. This profile of the Drd1 mutant rat offers the field of neuroscience a novel genetic rat model to study a series of psychiatric disorders including schizophrenia, autism, depression, bipolar disorder and drug addiction.
KW - Characterization
KW - Dopamine D1 receptor
KW - Mutant rat
KW - Schizophrenia
KW - Social cognition
UR - http://www.scopus.com/inward/record.url?scp=84993940178&partnerID=8YFLogxK
U2 - 10.1242/dmm.024752
DO - 10.1242/dmm.024752
M3 - Article
C2 - 27483345
AN - SCOPUS:84993940178
SN - 1754-8403
VL - 9
SP - 1147
EP - 1158
JO - DMM Disease Models and Mechanisms
JF - DMM Disease Models and Mechanisms
IS - 10
ER -